Manufacturers Life Insurance Company, The Savara Inc Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Savara Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 44,734 shares of SVRA stock, worth $118,992. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,734
Previous 44,956
0.49%
Holding current value
$118,992
Previous $190,000
27.89%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding SVRA
# of Institutions
141Shares Held
158MCall Options Held
55.6KPut Options Held
600-
Nea Management Company, LLC Timonium, MD24.5MShares$65.1 Million5.37% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$38.7 Million12.07% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$32.9 Million6.2% of portfolio
-
Vestal Point Capital, LP New York, NY10.8MShares$28.7 Million1.96% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.66MShares$23 Million1.59% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $303M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.